[HTML][HTML] EGFR and COX-2 dual inhibitor: the design, synthesis, and biological evaluation of novel chalcones

A Musa, EM Mostafa, SNA Bukhari, NH Alotaibi… - Molecules, 2022 - mdpi.com
For most researchers, discovering new anticancer drugs to avoid the adverse effects of
current ones, to improve therapeutic benefits and to reduce resistance is essential. Because …

Novel phenolic compounds as potential dual EGFR and COX-2 inhibitors: Design, semisynthesis, in vitro biological evaluation and in silico Insights

MA Abdelgawad, A Musa, AH Almalki… - Drug design …, 2021 - Taylor & Francis
Introduction Epidermal growth factor receptor (EGFR) inhibition is an imperative therapeutic
approach targeting various types of cancer including colorectal, lung, breast, and pancreatic …

[HTML][HTML] Novel quinoxaline derivatives as dual EGFR and COX-2 inhibitors: synthesis, molecular docking and biological evaluation as potential anticancer and anti …

EA Ahmed, MFA Mohamed, OA Omran - RSC advances, 2022 - pubs.rsc.org
Novel quinoxaline derivatives (2a–d, 3, 4a, 4b and 5–15) have been synthesized via the
reaction of 4-methyl-3-oxo-3, 4-dihydroquinoxaline-2-carbohydrazide (1) with different …

New ferrocene compounds as selective cyclooxygenase (COX-2) inhibitors: design, synthesis, cytotoxicity and enzyme-inhibitory activity

S Farzaneh, E Zeinalzadeh, B Daraei… - Anti-Cancer Agents …, 2018 - ingentaconnect.com
Background: Due to the astonishing properties of ferrocene and its derivatives, it has a
broad application in diverse areas. Numerous ferrocene derivatives demonstrated anti …

Novel diphenylthiazole derivatives with multi-target mechanism: Synthesis, docking study, anticancer and anti-inflammatory activities

AH Abdelazeem, MT El-Saadi, EG Said… - Bioorganic …, 2017 - Elsevier
Over the last few decades, a growing body of studies addressed the anticancer activity of
NSAIDs, particularly selective COX-2 inhibitors. However, their exact molecular mechanism …

Chalcones as Potential Cyclooxygenase-2 Inhibitors: A Review

M Mahboubi-Rabbani, R Zarei… - Anti-Cancer Agents …, 2024 - ingentaconnect.com
Cyclooxygenases (COXs) play a pivotal role in inflammation, a complex phenomenon
required in human defense, but also involved in the emergence of insidious human …

[HTML][HTML] Cytotoxicity of selected novel chalcone derivatives on human breast, lung and hepatic carcinoma cell lines

M Nakhjavani, A Zarghi, FH Shirazi - Iranian journal of …, 2014 - ncbi.nlm.nih.gov
Cancer is considered as a challenging deathly disease and discovering or synthesis of new
cytotoxic agents is a worldwide attempt. In this study, a group of recently synthesized …

Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX‐2 inhibitors

B Kaya Çavuşoğlu, BN Sağlık, U Acar Cevik… - Archiv der …, 2021 - Wiley Online Library
A new series of chalcones (1− 9) possessing an SO2CH3 COX‐2 pharmacophore at the
para position of the C‐1 phenyl ring was synthesized via the Claisen–Schmidt condensation …

Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies

AS El-Azab, AAM Abdel-Aziz… - Journal of enzyme …, 2018 - Taylor & Francis
A new series of NSAID thioesters were synthesized and evaluated for their in vitro antitumor
effects against a panel of four human tumor cell lines, namely: HepG2, MCF-7, HCT-116 and …

Novel pyrazole-based COX-2 inhibitors as potential anticancer agents: Design, synthesis, cytotoxic effect against resistant cancer cells, cell cycle arrest, apoptosis …

PA Halim, SMZ Sharkawi, MB Labib - Bioorganic Chemistry, 2023 - Elsevier
Novel differently substituted pyrazole derivatives were designed, synthesized and evaluated
for their anticancer activity. All compounds selectively inhibited COX-2 enzyme (IC 50 …